Future studies are also warranted on the genomic instability caused by the loss of UXT, focusing on possible deregulation of UXT interactions with URI, EVI1, and NF-κB, potentially providing cancer cells with a means to evade detection from inflammatory pathways and activation of immune signaling. The gene discussed is NFKB1; the disease is cancer.